Latest News and Press Releases
Want to stay updated on the latest news?
-
Vancouver, BC, Aug. 05, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to announce the appointment of David...
-
Vancouver, BC, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCPK:RBOHF), a publicly traded investment issuer focused on...
-
Delray Beach, FL, Aug. 05, 2025 (GLOBE NEWSWIRE) -- According to MarketsandMarkets, the global phytosterols market is poised for significant growth, projected to rise from USD 1.0 billion in 2023 to...
-
Stockholm, 5 augusti 2025 - Virtune meddelar idag att man har slutfört den månatliga rebalanseringen för Virtune Crypto Top 10 Index ETP SEK / EUR som är noterad på Nasdaq Stockholm för både...
-
Stockholm, 5 August 2025 - Virtune today announces the completion of the monthly rebalancing for the Virtune Crypto Top 10 Index ETP, listed on Nasdaq Stockholm for both the SEK-denominated (ISIN code...
-
Delivers first quarter of positive GAAP EPS in Company’s history since going public, announces initial results from AI Initiative SOMERSET, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc....
-
Phase 3 VELA program in hidradenitis suppurativa (HS) on track for an expected primary endpoint readout around September 2025 and an expected submission of a Biologic License Application (BLA) in the...
-
Envision Pharma Group appoints Tom Langan as Chief Executive Officer Leading industry executive with 30 years’ of experience providing technology-enabled solutions to life sciences companies ...
-
AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update Three active immunotherapies for precision prevention of neurodegeneration progressing through Phase 2 clinical...
-
First patient in Phase I/II clinical trial expected to be enrolled in Q4 2025UK Clinical Trial Application (CTA) approval shortly follows U.S. IND clearance and granting of European Medicine Agency...